New research has found that Cannnabidiol is active against Gram-positive bacteria, including those responsible for many serious infections (such as Staphyloccocus aureus and Streptococcus pneumoniae), with potency similar to that of established antibiotics such as vancomycin or daptomycin.
The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology.
Cannabidiol, the main non-psychoactive chemical compound extracted from cannabis and hemp plants, has been approved by FDA for the treatment of a form of epilepsy, and is being investigated for a number of other medical conditions, including, anxiety, pain and inflammation. While there is limited data to suggest Cannabidiol can kill bacteria, the drug has not been thoroughly investigated for its potential as an antibiotic.
Work led by Dr Mark Blaskovich at The University of Queensland’s Institute for Molecular Bioscience’s Centre for Superbug Solutions, in collaboration with Botanix Pharmaceuticals Ltd, an early stage drug discovery company investigating topical uses of synthetic cannabidiol for a range of skin conditions, found that Cannabidiol was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment.
“Given cannabidiol’s documented anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation,” said Dr. Blaskovich. “The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly attractive.”
Importantly, the drug retained its activity against bacteria that have become highly resistant to other common antibiotics. Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.
The project was co-funded by Botanix and Innovation Connections, an Australian government grant scheme to commercialize new products, processes and services. The paper will be presented on Sunday June 23rd from 11am-1 pm at the annual conference of the American Society for Microbiology, ASM Microbe 2019, at the Moscone Convention Center in San Francisco.
Learn more: Cannabidiol is a Powerful New Antibiotic
The Latest on: Cannnabidiol
via Google News
The Latest on: Cannnabidiol
- New CBD Store Opening Soon In Wading Riveron December 6, 2019 at 6:14 pm
Founder Christian Vergara said the new CBD store is "focused on safety, quality, and community." According to Harvard Health Publishing, CBD stands for cannabidiol. "It is the second most prevalent of ...
- XPhyto Therapeutics Developing Epilepsy Treatment with Oral Thin Film Delivery Systemon December 6, 2019 at 4:02 pm
The Company is focusing on generic cannabidiol-based dissolvable oral wafers for the treatment of severe childhood forms of Epilepsy, specifically Dravet syndrome ("Dravet") and Lennox-Gastaut ...
- CBD research trends in 2019on December 6, 2019 at 11:47 am
Recent developments in how CBD (cannabidiol) is regulated in the US have made it much easier to purchase CBD products. Changes to how the federal government views CBD are also making it easier for ...
- Canopy, the biggest player in Canadian cannabis, is finally entering the USon December 6, 2019 at 9:42 am
For the last few years, products containing cannabidiol—the cannabis-derived compound commonly known as CBD—have proliferated, from vape pens to face creams, tinctures to dog treats. First & Free ...
- Forget the FDA! You Can Still Invest in CBD and Make Moneyon December 6, 2019 at 8:51 am
Follow @TMFUltraLong Although marijuana stocks have been a hot investing trend for years, perhaps nothing eclipses the excitement that's surrounded cannabidiol (CBD), the nonpsychoactive cannabinoid ...
- Why CBD may deserve a place in your skin care routineon December 6, 2019 at 7:33 am
CBD oil, or cannabidiol oil, can now be found in skin care products, hair care and beyond. But do these CBD beauty products live up to the hype? We find out.
- Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Researchon December 5, 2019 at 4:03 pm
TEL AVIV, Israel and BETHESDA, Maryland, Dec. 5, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects ...
- CBD-Based Skincare and Wellness Products For Cannabidiol Newbieson December 4, 2019 at 8:46 am
Others attest that tea tree oil is the cure-all for skin woes. Then there’s Argan, Marula and most recently, Pili oils. One particular natural ingredient that’s piqued interest is cannabidiol or CBD ...
- Willow Biosciences Comments on Descheduling of Partner's Cannabidiol by U.S. Drug Enforcement Agencyon December 3, 2019 at 3:30 am
CALGARY, Dec. 3, 2019 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (WLLW)(otcqb:CANSF), a Canadian biotechnology company and a leading developer in biosynthetically produced ...
- FDA Issues Warning on Products That Contain Cannabidiolon December 2, 2019 at 5:44 pm
Share on Pinterest Cannabidiol has been touted as a treatment for chronic pain, anxiety, cancer, and Alzheimer’s disease without a lot of scientific evidence. Getty Images Officials at the FDA are ...
via Bing News